Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Boston Children's Hospital
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Children's Hospital of Philadelphia
Stanford University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
University of Texas Southwestern Medical Center
Celgene
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Hospital of Philadelphia
Columbia University
Hospital Universitari Vall d'Hebron Research Institute
Wake Forest University Health Sciences
Medical College of Wisconsin
University of California, San Francisco
Children's Mercy Hospital Kansas City
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
New York Medical College
Emory University
University of British Columbia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Rabin Medical Center
Columbia University
Office of Rare Diseases (ORD)